Quirin Hammer

Title: Quirin Hammer: Innovator in Immunotherapy

Introduction

Quirin Hammer is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunotherapy, particularly in the activation and expansion of natural killer (NK) cells. His innovative work has the potential to impact the treatment of various medical conditions associated with pathogenic cells.

Latest Patents

Quirin Hammer holds a patent for the invention titled "Activation and expansion of NKG2C+ NK cells." This patent involves an isolated peptide that consists of 9 to 30 amino acids, specifically designed to expand and activate NKG2C+ natural killer cells. The peptide includes an amino acid sequence according to SEQ ID NO 1 (VMAPRTLXL), where X represents an amino acid with a hydrophobic side chain. The invention also encompasses a genetically modified virus encoding this peptide for use as a medicament.

Career Highlights

Quirin Hammer is affiliated with the Deutsches Rheuma-Forschungszentrum Berlin, where he conducts his research and development activities. His work focuses on advancing therapeutic strategies that leverage the immune system to combat diseases.

Collaborations

Quirin collaborates with esteemed colleagues, including Chiara Romagnani and Timo Rückert, to further enhance the impact of his research in the field of immunotherapy.

Conclusion

Quirin Hammer's innovative contributions to the activation and expansion of NK cells represent a significant advancement in medical science. His work continues to pave the way for new therapeutic approaches in treating diseases associated with pathogenic cells.